By Myles Starr
The FDA recently raised concerns about the use of probiotics in hospitalized preterm infants.
The agency received an adverse event report on July 31 regarding a preterm infant who was treated with the probiotic Evivo with MCT Oil (Infinant Health) as part of in-hospital care to prevent necrotizing enterocolitis. After receiving Evivo, the patient developed sepsis, caused by the bacterium Bifidobacterium longum (which is present in Evivo), and subsequently died. This incident is one